How many studies have been conducted on Bifidobacterium Infantis?

BiohacksAI has indexed 139 PubMed studies on Bifidobacterium Infantis, including 11 randomized controlled trials (RCTs). 27% of studies involve human subjects.

What are the main research areas for Bifidobacterium Infantis?

The primary research domains for Bifidobacterium Infantis are 🦠 Gut & Microbiome, 🔬 Oncology, 🔬 Inflammation. This is based on analysis of 139 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Bifidobacterium Infantis

A subspecies of Bifidobacterium longum that occurs in the GASTROINTESTINAL TRACT of human infants and is used as a PROBIOTIC. It may also be used in the treatment of IRRITABLE BOWEL SYNDROME.

139+ PubMed studies analyzed · 11 RCTs · Evidence Score: 48.2

Research Domains

Bifidobacterium Infantis has been studied across 12 research domains including 🦠 Gut & Microbiome, 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity, 😴 Sleep. The primary research focus is 🦠 Gut & Microbiome with 91% of studies addressing this area.

Loading evidence profile...

This evidence profile for Bifidobacterium Infantis is generated deterministically from 139 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.